13-48380073-T-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM1BP4_ModerateBS2
The NM_000321.3(RB1):āc.1410T>Gā(p.Ile470Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000793 in 1,386,580 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000321.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RB1 | NM_000321.3 | c.1410T>G | p.Ile470Met | missense_variant | 15/27 | ENST00000267163.6 | NP_000312.2 | |
RB1 | NM_001407165.1 | c.1410T>G | p.Ile470Met | missense_variant | 15/27 | NP_001394094.1 | ||
RB1 | NM_001407166.1 | c.1410T>G | p.Ile470Met | missense_variant | 15/17 | NP_001394095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RB1 | ENST00000267163.6 | c.1410T>G | p.Ile470Met | missense_variant | 15/27 | 1 | NM_000321.3 | ENSP00000267163.4 | ||
RB1 | ENST00000650461.1 | c.1410T>G | p.Ile470Met | missense_variant | 15/27 | ENSP00000497193.1 |
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 150578Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.00000745 AC: 1AN: 134210Hom.: 0 AF XY: 0.0000136 AC XY: 1AN XY: 73508
GnomAD4 exome AF: 0.00000647 AC: 8AN: 1236002Hom.: 0 Cov.: 22 AF XY: 0.00000650 AC XY: 4AN XY: 615652
GnomAD4 genome AF: 0.0000199 AC: 3AN: 150578Hom.: 0 Cov.: 30 AF XY: 0.0000136 AC XY: 1AN XY: 73502
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2024 | The p.I470M variant (also known as c.1410T>G), located in coding exon 15 of the RB1 gene, results from a T to G substitution at nucleotide position 1410. The isoleucine at codon 470 is replaced by methionine, an amino acid with highly similar properties. Although this particular variant has not been reported in the literature, a different amino acid change at this same position (p.Ile470Phe) has been reported in two Chinese patients with unilateral retinoblastoma (Li T et al. Int J Clin Exp Pathol 2016;9(2):2120-2126). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | May 20, 2021 | - - |
Retinoblastoma Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Sep 27, 2024 | This missense variant replaces isoleucine with methionine at codon 470 of the RB1 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with RB1-related disorders in the literature. This variant has been identified in 2/163858 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Malignant tumor of urinary bladder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jul 28, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at